Expression of XPG Protein in Human Normal and Tumor Tissues

Overview

Journal Int J Clin Exp Pathol

Specialty Pathology

Date 2013 Jan 19

PMID 23330005

Citations 5

Authors

Miguel Aracil

Lisa M Dauffenbach

Marta Martinez Diez

Rana Richeh

Victoria Moneo

Juan Fernando Martinez Leal

Luis Francisco Garcia Fernandez

Christopher A Kerfoot

Carlos M Galmarini

Affiliations

Soon will be listed here.

Abstract

XPG (Xeroderma pigmentosum group G complementing factor) is a protein associated with DNA repair and transcription. Point mutations in ERCC5, the gene coding for XPG, cause the cancer-prone disorder xeroderma pigmentosum (XP) while truncation mutations give rise to individuals with the combined clinical features of XP and Cockayne syndrome. Polymorphisms of ERCC5 or alterations in XPG mRNA expression were also associated to an increase risk of different cancers types and to prognosis of cancer patients. However, the expression of XPG protein in different normal or tumor human tissues is not well known. In the present work, we have validated an immunohistochemistry (IHC) assay for detection of expression levels of XPG protein in FFPE human tissue samples. We have also tested this IHC assay in different normal and tumor human tissues. On a microarray containing 28 normal cores, positive staining was observed in 60% of the samples. The highest staining was detected in adrenal gland, breast, colon, heart, kidney, thyroid and tongue. In tumors, positive staining was observed in 9 of 10 breast cancer samples and in all 5 ovarian cancer and 5 sarcomas samples. Subcellular localization was predominantly nuclear. The use of this validated methodology would help to interpret the role of XPG in tumorogenesis and its use as a possible prognostic or predictive factor.

Citing Articles

Elucidation of Increased Cervical Cancer Risk Due to Polymorphisms in XRCC1 (R399Q and R194W), ERCC5 (D1104H), and NQO1 (P187S).

Das A, Saini S, Tyagi S, Chaudhary N, Agarwal S Reprod Sci. 2022; 30(4):1118-1132.

PMID: 36195778 DOI: 10.1007/s43032-022-01096-6.

DNA repair and cell synthesis proteins: immunohistochemical expression and correlation with recurrence-regrowth in meningiomas.

Silva C, Ongaratti B, Trott G, Araujo B, Rech C, Coutinho L J Mol Histol. 2020; 51(4):411-420.

PMID: 32617895 DOI: 10.1007/s10735-020-09892-7.

Identification of a Splenic Marginal Zone Lymphoma Signature: Preliminary Findings With Diagnostic Potential.

Robinson J, Greiner T, Bouska A, Iqbal J, Cutucache C Front Oncol. 2020; 10:640.

PMID: 32457837 PMC: 7225304. DOI: 10.3389/fonc.2020.00640.

Splice variants of the endonucleases XPF and XPG contain residual DNA repair capabilities and could be a valuable tool for personalized medicine.

Lehmann J, Schubert S, Seebode C, Apel A, Ohlenbusch A, Emmert S Oncotarget. 2018; 9(1):1012-1027.

PMID: 29416673 PMC: 5787415. DOI: 10.18632/oncotarget.23105.

Expression of XPG protein in the development, progression and prognosis of gastric cancer.

Deng N, Liu J, Sun L, Xu Q, Duan Z, Dong N PLoS One. 2014; 9(9):e108704.

PMID: 25268735 PMC: 4182552. DOI: 10.1371/journal.pone.0108704.

References

Berhane N, Sobti R, Abdul Mahdi S . DNA repair genes polymorphism (XPG and XRCC1) and association of prostate cancer in a north Indian population. Mol Biol Rep. 2011; 39(3):2471-9. DOI: 10.1007/s11033-011-0998-5. View

Reardon J, Vaisman A, Chaney S, Sancar A . Efficient nucleotide excision repair of cisplatin, oxaliplatin, and Bis-aceto-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) platinum intrastrand DNA diadducts. Cancer Res. 1999; 59(16):3968-71. View

He J, Qiu L, Wang M, Hua R, Zhang R, Yu H . Polymorphisms in the XPG gene and risk of gastric cancer in Chinese populations. Hum Genet. 2012; 131(7):1235-44. DOI: 10.1007/s00439-012-1152-8. View

Goncalves F, Francisco G, de Souza S, Luiz O, Festa-Neto C, Sanches J . European ancestry and polymorphisms in DNA repair genes modify the risk of melanoma: a case-control study in a high UV index region in Brazil. J Dermatol Sci. 2011; 64(1):59-66. DOI: 10.1016/j.jdermsci.2011.06.003. View

Friedberg E, Wood R . New insights into the combined Cockayne/xeroderma pigmentosum complex: human XPG protein can function in transcription factor stability. Mol Cell. 2007; 26(2):162-4. DOI: 10.1016/j.molcel.2007.04.002. View

Harper J, Elledge S . The DNA damage response: ten years after. Mol Cell. 2007; 28(5):739-45. DOI: 10.1016/j.molcel.2007.11.015. View

ODonovan A, Scherly D, Clarkson S, Wood R . Isolation of active recombinant XPG protein, a human DNA repair endonuclease. J Biol Chem. 1994; 269(23):15965-8. View

Reardon J, Bessho T, Kung H, Bolton P, Sancar A . In vitro repair of oxidative DNA damage by human nucleotide excision repair system: possible explanation for neurodegeneration in xeroderma pigmentosum patients. Proc Natl Acad Sci U S A. 1997; 94(17):9463-8. PMC: 23224. DOI: 10.1073/pnas.94.17.9463. View

Hanawalt P . Paradigms for the three rs: DNA replication, recombination, and repair. Mol Cell. 2007; 28(5):702-7. DOI: 10.1016/j.molcel.2007.11.014. View

10.

Italiano A, Laurand A, Laroche A, Casali P, Sanfilippo R, Cesne A . ERCC5/XPG, ERCC1, and BRCA1 gene status and clinical benefit of trabectedin in patients with soft tissue sarcoma. Cancer. 2011; 117(15):3445-56. DOI: 10.1002/cncr.25925. View

11.

Takebayashi Y, Pourquier P, Zimonjic D, Nakayama K, Emmert S, Ueda T . Antiproliferative activity of ecteinascidin 743 is dependent upon transcription-coupled nucleotide-excision repair. Nat Med. 2001; 7(8):961-6. DOI: 10.1038/91008. View

12.

Lehmann A . DNA repair-deficient diseases, xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. Biochimie. 2004; 85(11):1101-11. DOI: 10.1016/j.biochi.2003.09.010. View

13.

Sarker A, Tsutakawa S, Kostek S, Ng C, Shin D, Peris M . Recognition of RNA polymerase II and transcription bubbles by XPG, CSB, and TFIIH: insights for transcription-coupled repair and Cockayne Syndrome. Mol Cell. 2005; 20(2):187-98. DOI: 10.1016/j.molcel.2005.09.022. View

14.

Trego K, Chernikova S, Davalos A, Perry J, Finger L, Ng C . The DNA repair endonuclease XPG interacts directly and functionally with the WRN helicase defective in Werner syndrome. Cell Cycle. 2011; 10(12):1998-2007. PMC: 3154418. DOI: 10.4161/cc.10.12.15878. View

15.

ODonovan A, Wood R . Identical defects in DNA repair in xeroderma pigmentosum group G and rodent ERCC group 5. Nature. 1993; 363(6425):185-8. DOI: 10.1038/363185a0. View

16.

Graf N, Ang W, Zhu G, Myint M, Lippard S . Role of endonucleases XPF and XPG in nucleotide excision repair of platinated DNA and cisplatin/oxaliplatin cytotoxicity. Chembiochem. 2011; 12(7):1115-23. PMC: 3081389. DOI: 10.1002/cbic.201000724. View

17.

Reardon J, Sancar A . Nucleotide excision repair. Prog Nucleic Acid Res Mol Biol. 2005; 79:183-235. DOI: 10.1016/S0079-6603(04)79004-2. View

18.

Sabatino M, Marabese M, Ganzinelli M, Caiola E, Geroni C, Broggini M . Down-regulation of the nucleotide excision repair gene XPG as a new mechanism of drug resistance in human and murine cancer cells. Mol Cancer. 2010; 9:259. PMC: 2955619. DOI: 10.1186/1476-4598-9-259. View

19.

Schoffski P, Taron M, Jimeno J, Grosso F, Sanfilipio R, Casali P . Predictive impact of DNA repair functionality on clinical outcome of advanced sarcoma patients treated with trabectedin: a retrospective multicentric study. Eur J Cancer. 2011; 47(7):1006-12. DOI: 10.1016/j.ejca.2011.01.016. View

20.

Evans E, Moggs J, Hwang J, Egly J, Wood R . Mechanism of open complex and dual incision formation by human nucleotide excision repair factors. EMBO J. 1997; 16(21):6559-73. PMC: 1170260. DOI: 10.1093/emboj/16.21.6559. View